Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Challenges in the Manufacture of Antibody Drug Conjugates

Antibody drug conjugates (ADCs) represent potent new weapons in the anticancer drug arsenal but their manufacture presents a series of engineering and chemistry challenges.

By Thomas Roher at Lonza Custom Manufacturing, Chemical Manufacturing (March 2010)

Keywords: manufacture, Lonza, ADC, Antibody, weapon, drug, cancer, molecule, chemotherapeutic, silver bullet, challenge, Rohrer

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |